Selective Degradation and Inhibition of SARS-CoV-2 3CL&lt;sup&gt;pro&lt;/sup&gt; by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics. Here, MMP14 is linked to COVID-19.